TREX1 and systemic lupus erythematosus: Among the patients with a TREX1 mutation, 60% of subjects are documented to have at least one of the following lupus features: antibodies to extractable nuclear antigens (ENA), ANA and anti-dsDNA, thrombocytopenia, leukopenia, skin lesions, oral ulcers and arthritis [127].